GEBBIA, VITTORIO
GEBBIA, VITTORIO
Dipartimento di Medicina e Chirurgia
112. UN NUOVO INDICE PROGNOSTICO-TERAPEUTICO IN ONCOLOGIA GERIATRICA
2007-01-01 Bellavia, G; Dominguez, L. J.; Deleo, M; Bajardi, E; Belvedere, M; Gebbia, V; Barbagallo, M
5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: a multicenter randomised phase II study of the Southern Italy Oncology Group
2000-01-01 Maiello, E; Gebbia, V; Giuliani, F; Paoletti, G; Gebbia, N; Cigolari, S; Fortunato, S; Pedicini, T; Borsellino, N; Lopez, M; Colucci, G.
5-fluorouracil and levofolinic acid with or without recombinant interferon-2b in patients with advanced colorectal carcinoma: a randomized multicenter study with stratification for tumor burden and liver involvement by the Southern Italy Oncology Group
1999-01-01 Colucci, G; Maiello, E; Gebbia, V; Giuliani, F; Serravezza, G; Lelli, G; Leo, S; Filippelli, G; Nicolella, G; Brandi, M.
5-Fluorouracil and Recombinant Alpha Interferon-2a in the Treatment of Advanced Colorectal Carcinoma: a Dose Optimization Study
1990-01-01 Palmeri, S.; Gebbia, V.; Rausa, L.
5-fluorouracil plus folinic acid with or without ifosfamide in advanced colorectal cancer: a phase II randomized trial
2000-01-01 Sdrobolini, A; Contu, A; Massidda, B; Gasperoni, S; Recchia, F; Iannelli, A; Tomao, S; Romiti, A; Raffaele, M; Ortu, S; Campisi, C; Gebbia, V; Olmeo, N; Ionta, Mt; Angiona, S; DI COSTANZO, F.
5-fluorouracil plus high dose levofolinic acid and oral hydroxyurea for the treatment of primary hepatocellular carcinomas: Results of a phase II multicenter study of the Southern Italy Oncology Group (G.O.I.M.)
1999-01-01 Gebbia, V.; Maiello, E.; Serravezza, G.; Giotta, F.; Testa, A.; Borsellino, N.; Pezzella, G.; Colucci, G.
[First line chemotherapy in non-small cell lung carcinoma: a solved dilemma]
2008-01-01 Gebbia, Vittorio
A combination of platinum and tamoxifen in advanced ovarian cancer failing platinum-based chemotherapy: results of a Phase II study
2001-01-01 BENEDETTI PANICI, P; Greggi, S; Amoroso, M; Scambia, G; Battaglia, Fa; Gebbia, V; Salerno, G; Paratore, Mp; Mancuso, S.
A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin plus etoposide in extensive small-cell lung cancer (SCLC) patients The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial
2017-01-01 Morabito, A; Daniele, G; Costanzo, R; Favaretto, Ag; Filipazzi, V; Rossi, A; Gebbia, V; Castiglione, F; Cavanna, L; Maiello, E; Sandomenico, C; Bonanno, L; Piazza, E; Maione, P; Piccirillo, Mc; Di Maio, M; Rocco, G; Gallo, C; Perrone, F; Gridelli, C
A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations
2021-01-01 Santarpia, Mariacarmela; Massafra, Marco; Gebbia, Vittorio; D'Aquino, Antonio; Garipoli, Claudia; Altavilla, Giuseppe; Rosell, Rafael
A phase I study of cisplatinum plus 5-fluorouracil in modulation with citrovorum factor in metastatic colorectal carcinoma
1991-01-01 Palmeri, S; Gebbia, V; Russo, A; Gebbia, N; Rustum, Y; Rausa, L; Creaven, P; Petrelli, N
A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer
2011-01-01 Amadori, D; Milandri, C; Comella, G; Saracchini, S; Salvagni, S; Barone, C; Bordonaro, R; Gebbia, V; Barbato, A; Serra, P; Gattuso, D; Nanni, O; Baconnet, B; Gasparini, G.
A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer
2011-01-01 Amadori, D; Milandri, C; Comella, G; Saracchini, S; Salvagni, S; Barone, C; Bordonaro, R; Gebbia, V; Barbato, A; Serra, P; Gattuso, D; Nanni, O; Baconnet, B; Gasparini, G.
A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial
2009-01-01 Pisano, C; Morabito, A; Sorio, R; Breda, E; Lauria, R; Gebbia, V; Scaltriti, L; Scalone, S; Zagonel, V; Greggi, S; Beneduce, G; Losito, S; Gallo, C; Di Maio, M; Forestieri, V; Pignata, S.
A Phase II Study of Levofolinic Acid and 5-Fluorouracil Plus Cisplatin in Patients with Advanced Head and Neck Squamous Cell Carcinoma
1993-01-01 Gebbia, Vittorio; Testa, Antonio; Valenza, Roberto; Zerillo, Giuseppe; Restivo, Salvatore; Cupido, Gianfranco; Ingria, Federico; Barbaccia, Carmelo; Spadafora, Giovanni; Cannata, Giuseppe; Gebbia, Nicola
A phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in pretreated patients with small-cell lung cancer.
2013-01-01 de Marinis, F; Atmaca, A; Tiseo, M; Giuffreda, L; Rossi, A; Gebbia, V; D'Antonio, C; Dal Zotto, L; Al-Batran, Se; Marsoni, S; Wolf, M.
A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group
1995-01-01 Di Bartolomeo, M; Bajetta, E; Bochicchio, Am; Carnaghi, C; Somma, L; Mazzaferro, V; Visini, M; Gebbia, V; Tumolo, S; Ballatore, P.
A phase II trial of etoposide, folinic acid, fluorouracil and epirubicin in advanced pancreatic carcinoma
1998-01-01 Maiello, E; Gebbia, V; Giuliani, F; Testa, A; Giotta, F; Gebbia, N; Colucci, G
A Phase I–II Study on the Toxicity and Therapeutic Efficacy of 5-Fluorouracil in Combination with Leucovorin and Cisplatinum in Patients with Advanced Colorectal Carcinoma
1990-01-01 Palmeri, S.; Russo, A.; Gebbia, V.; Borsellino, N.; Gebbia, N.; Rustum, Y.; Rausa, L.
A Phase I—II Study of Cyclophosphamide, Epidoxorubicin, Levofolinic Acid/5-Fluorouracil and Recombinant Human Granulocyte Colony Stimulating Factor in Metastatic Breast Carcinoma
1994-01-01 Callari, Angela; Gebbia, Vittorio; Testa, Antonio; Cusimano, Maria Pia; Cipolla, Calogero; Amato, Carmela; Cannata, Giuseppe; Latteri, Mario Adelfio; Garascia, Cristina; Gebbia, Nicola; Agostara, Biagio